[A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)].
D000368:Aged; D001777:Blood Coagulation; D005164:Factor IX / Q000627:therapeutic use*; D015949:Factor IXa; D005165:Factor V / Q000037:antagonists & inhibitors*; D005169:Factor VIII / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D010974:Platelet Aggregation; D012811:Sigmoid Neoplasms / Q000097:blood* / Q000188:drug therapy
D005165:Factor V; D005169:Factor VIII; D005164:Factor IX; D015949:Factor IXa